Cubosomes; a Promising Carrier for Encapsulation of Drugs, Alginate-Based Compounds and Theranostic Applications

Cubosomes, a novel class of nanoparticles, have gained substantial interest in the field of drug delivery because of their distinctive bicontinuous cubic structure. Cubosomes are made up of amphiphilic lipid and stabilizers and provide robust and adaptable platform for enclosing a variety of drugs. Because of their natural high surface area and capacity to encapsulate both hydrophilic and hydrophobic materials, cubosomes are incredibly effective in drug delivery applications. Their potential for therapeutic applications is further enhanced by their biocompatibility and sustained drug release. Cubosomes provide intriguing drug delivery system for oral, ocular, dermatological, and intravenous applications. Alginate-based cubosomes represent a significant advancement in targeted drug delivery systems. Their pH-responsive and nontoxic nature, combined with the ability to control the release of encapsulated drugs, makes them a versatile platform for colon-targeted multidrug delivery. Researchers have focused their views on diagnostic aspect of cubosomes. Their hydrophobic volume and minimal surface allow the encapsulation of imaging agent and therapeutic agent in combination. In diagnosis, cubosomes loaded with imaging agent allow for real-time tracking and imaging of medication distribution and therapy response. The integration of therapeutic and diagnostic agent in cubosomes heralds a new era in nanomedicine.